Key result
Direct thrombin inhibition reduces both platelet and fibrin deposition in rat thrombosis unlike platelet inhibitors.
In a rat model of arterial thrombosis, thrombin plays a key role in initiating thrombus formation, with direct thrombin inhibition effectively reducing both platelet and fibrin deposition.
Answers are grounded in this paper and cite their sources.
Does not yet alter clinical antithrombotic choices; hypothesis-generating for differential thrombus modulation in arterial injury.
A technically simple model of arterial thrombosis in the rat, induced by a crush injury to the dorsal aorta is described. The mechanical injury to the artery caused deep medial injury and the formation of a platelet-rich thrombus with associated fibrin formation which was assessed both radiometrically and morphometrically. No significant inclusion of erythrocytes was noted in the thrombus. Administration of the platelet inhibitors aspirin, BM 13505 (a thromboxane receptor antagonist) or CGS 12970 (a thromboxane synthase inhibitor) reduced the extent of platelet deposition on the injured vessel, but no decrease in fibrin(ogen) was observed. In contrast, infusion of prostacyclin resulted in reductions in both these components of the thrombus. In studies involving inhibition of thrombin activity, the direct thrombin inhibitor CGP 39393 (recombinant desulphatohirudin) inhibited both the platelet and fibrin(ogen) deposition. The indirect thrombin inhibitors were less effective; unfractionated heparin and low-molecular-weight heparin inhibited both platelet and fibrin(ogen) deposition but only at doses which rendered the blood uncoagulable, as evaluated by the activated partial thromboplastin time. Dermatan sulphate only inhibited platelet deposition. The results suggest that thrombin plays a key role in the initiation of thrombus formation in this experimental model. The agonist prostaglandins (PGG2, PGH2, and TXA2) would appear to have a supporting role in the platelet deposition onto the thrombotic surface but do not have a role to play with respect to fibrin(ogen) deposition.
No takes yet. Share an insight, caveat, or question.
Butler et al. (1992) studied Arterial thrombosis. Platelet inhibitors and thrombin inhibitors was evaluated on Platelet and fibrin(ogen) deposition. In a rat model of arterial thrombosis, direct thrombin inhibition reduced both platelet and fibrin deposition, whereas platelet inhibitors primarily reduced platelet deposition without affecting fibrin.
Synapse has enriched 10 related papers. Consider them for comparative context: